Drug Shortage Report for SODIUM CHLORIDE INJECTION, USP
Report ID | 158798 |
Drug Identification Number | 02139510 |
Brand name | SODIUM CHLORIDE INJECTION, USP |
Common or Proper name | Sodium Chloride Injection, USP |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | SODIUM CHLORIDE |
Strength(s) | 234MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 100mL |
ATC code | B05XA |
ATC description | I.V. SOLUTION ADDITIVES |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2021-10-01 |
Estimated end date | 2022-11-01 |
Actual end date | 2022-10-04 |
Shortage status | Resolved |
Updated date | 2022-10-05 |
Company comments | We will be encountering a supply interruption on our Sodium Chloride Injection, USP 4mEq/mL Maxivial® 100 mL effective September 1, 2022 until November 1, 2022. Effective September 1, 2022 allocations for our 200 mL will be increased to cover 100% of 200mL demand plus 100% of 100 mL demand on a mL:mL basis. Please see communication for further details. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2022-10-05 | English | Compare |
v12 | 2022-10-03 | French | Compare |
v11 | 2022-10-03 | English | Compare |
v10 | 2022-09-01 | French | Compare |
v9 | 2022-09-01 | English | Compare |
v8 | 2022-08-21 | French | Compare |
v7 | 2022-08-21 | English | Compare |
v6 | 2022-07-29 | French | Compare |
v5 | 2022-07-29 | English | Compare |
v4 | 2022-06-27 | French | Compare |
v3 | 2022-06-27 | English | Compare |
v2 | 2022-04-13 | French | Compare |
v1 | 2022-04-13 | English | Compare |
Showing 1 to 13 of 13